629 related articles for article (PubMed ID: 30885850)
21. Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.
Nakajima T; Yasufuku K; Nakagawara A; Kimura H; Yoshino I
Chest; 2011 Nov; 140(5):1319-1324. PubMed ID: 21527506
[TBL] [Abstract][Full Text] [Related]
22. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.
Esterbrook G; Anathhanam S; Plant PK
Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886
[TBL] [Abstract][Full Text] [Related]
23. The Performance of an Extended Next Generation Sequencing Panel Using Endobronchial Ultrasound-Guided Fine Needle Aspiration Samples in Non-Squamous Non-Small Cell Lung Cancer: A Pragmatic Study.
Zhang C; Kim RY; McGrath CM; Andronov M; Haas AR; Ma KC; Lanfranco AR; Hutchinson CT; Morrissette JJD; DiBardino DM
Clin Lung Cancer; 2023 Mar; 24(2):e105-e112. PubMed ID: 36599742
[TBL] [Abstract][Full Text] [Related]
24. Epidermal Growth Factor Receptor (EGFR) Mutations and Anaplastic Lymphoma Kinase/Oncogene or C-Ros Oncogene 1 (ALK/ROS1) Fusions Inflict Non-Small Cell Lung Cancer (NSCLC) Female Patients Older Than 60 Years of Age.
Ke L; Xu M; Jiang X; Sun X
Med Sci Monit; 2018 Dec; 24():9364-9369. PubMed ID: 30580372
[TBL] [Abstract][Full Text] [Related]
25. Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments.
Zugazagoitia J; Rueda D; Carrizo N; Enguita AB; Gómez-Sánchez D; Díaz-Serrano A; Jiménez E; Mérida A; Calero R; Lujan R; De Miguel E; Gámez P; Díaz-Hellín V; Nuñez JA; Iglesias L; Ferrer I; Paz-Ares L; Ponce-Aix S
Clin Lung Cancer; 2018 Jan; 19(1):65-73.e7. PubMed ID: 28780976
[TBL] [Abstract][Full Text] [Related]
26. Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.
Clavé S; Rodon N; Pijuan L; Díaz O; Lorenzo M; Rocha P; Taus Á; Blanco R; Bosch-Barrera J; Reguart N; de la Torre N; Oliveras G; Espinet B; Bellosillo B; Puig X; Arriola E; Salido M
Clin Lung Cancer; 2019 Jul; 20(4):e421-e429. PubMed ID: 30898567
[TBL] [Abstract][Full Text] [Related]
27. Comparison of adequacy between transbronchial lung cryobiopsy samples and endobronchial ultrasound-guided transbronchial needle aspiration samples for next-generation sequencing analysis.
Tone M; Inomata M; Awano N; Kuse N; Takada K; Minami J; Muto Y; Fujimoto K; Kumasaka T; Izumo T
Thorac Cancer; 2021 Jan; 12(2):251-258. PubMed ID: 33270369
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective.
Aggarwal A; Sharma S; Brar Z; Kumar V; Kumar A; Katara R; Mohanty SK
Pathol Res Pract; 2024 Jan; 253():155013. PubMed ID: 38096714
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of lung cancer biomarkers profile for the decision of targeted therapy in EBUS-TBNA cytological samples.
Gürün Kaya A; Çiledağ A; Erol S; Öz M; Doğan Mülazımoğlu D; Işık Ö; Özakıncı H; Çiftçi F; Şen E; Ceyhan K; Kaya A; Karnak D; Çelik G; İsmail S
Scott Med J; 2022 Feb; 67(1):18-27. PubMed ID: 35147461
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the slow-pull and aspiration methods of endobronchial ultrasound-guided transbronchial needle aspiration for next-generation sequencing-compatible tissue collection in non-small cell lung cancer.
Kajita Y; Teranishi S; Sawazumi T; Watanabe H; Nagaoka S; Tanaka A; Suzukawa Y; Motobayashi Y; Hirose T; Maeda C; Seki K; Tashiro K; Kobayashi N; Yamamoto M; Kudo M; Inayama Y; Kaneko T
Cancer Med; 2023 Oct; 12(19):19512-19522. PubMed ID: 37732488
[TBL] [Abstract][Full Text] [Related]
31. Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle Aspiration.
Casadio C; Guarize J; Donghi S; Di Tonno C; Fumagalli C; Vacirca D; Dell'Orto P; De Marinis F; Spaggiari L; Viale G; Barberis M
Am J Clin Pathol; 2015 Oct; 144(4):629-34. PubMed ID: 26386084
[TBL] [Abstract][Full Text] [Related]
32. Developing a New qPCR-Based System for Screening Mutation.
Zhu J; Zhao Y; Liu M; Gonzalez-Rivas D; Xu X; Cai W; Qi H; Dai L; Wang Z; Song X; Jiang G; Yang Y
Small; 2019 Mar; 15(9):e1805285. PubMed ID: 30677225
[TBL] [Abstract][Full Text] [Related]
33. Next-generation sequencing of liquid-based cytology non-small cell lung cancer samples.
Reynolds JP; Zhou Y; Jakubowski MA; Wang Z; Brainard JA; Klein RD; Farver CF; Almeida FA; Cheng YW
Cancer Cytopathol; 2017 Mar; 125(3):178-187. PubMed ID: 28085233
[TBL] [Abstract][Full Text] [Related]
34. EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.
Sakairi Y; Nakajima T; Yasufuku K; Ikebe D; Kageyama H; Soda M; Takeuchi K; Itami M; Iizasa T; Yoshino I; Mano H; Kimura H
Clin Cancer Res; 2010 Oct; 16(20):4938-45. PubMed ID: 20926401
[TBL] [Abstract][Full Text] [Related]
35. Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations.
Magnini D; Fuso L; Varone F; D'Argento E; Martini M; Pecoriello A; Di Noia V; Arciuolo D; Fadda G; Rindi G; Richeldi L
Mol Diagn Ther; 2018 Dec; 22(6):723-728. PubMed ID: 30276554
[TBL] [Abstract][Full Text] [Related]
36. Resistance Mechanisms to Targeted Therapies in
McCoach CE; Le AT; Gowan K; Jones K; Schubert L; Doak A; Estrada-Bernal A; Davies KD; Merrick DT; Bunn PA; Purcell WT; Dziadziuszko R; Varella-Garcia M; Aisner DL; Camidge DR; Doebele RC
Clin Cancer Res; 2018 Jul; 24(14):3334-3347. PubMed ID: 29636358
[No Abstract] [Full Text] [Related]
37. Randomized Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration With and Without Rapid On-site Evaluation for Lung Cancer Genotyping.
Trisolini R; Cancellieri A; Tinelli C; de Biase D; Valentini I; Casadei G; Paioli D; Ferrari F; Gordini G; Patelli M; Tallini G
Chest; 2015 Dec; 148(6):1430-1437. PubMed ID: 26158441
[TBL] [Abstract][Full Text] [Related]
38. Protocol to Improve Genotyping of Non-Small-Cell Lung Cancer Diagnosed Using EBUS-TBNA.
Bellinger CR; Sharma D; Dotson T; Ruiz J; Parks G; Haponik EF
South Med J; 2018 Oct; 111(10):601-606. PubMed ID: 30285266
[TBL] [Abstract][Full Text] [Related]
39. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy.
Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S
J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592
[TBL] [Abstract][Full Text] [Related]
40. Pyrosequencing analysis of EGFR and KRAS mutations in EUS and EBUS-derived cytologic samples of adenocarcinomas of the lung.
Stigt JA; 'tHart NA; Knol AJ; Uil SM; Groen HJ
J Thorac Oncol; 2013 Aug; 8(8):1012-8. PubMed ID: 23807543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
